THERAPEUTIC INJECTIONS
Chronic Migraine
Migraines are estimated to affect around 15% of the world’s population. In Canada, at least 2.6 million adult women and nearly one million men experience migraine. It has been calculated that every year 3% of subjects suffering from migraine experience an increase in frequency of attacks, reaching and exceeding 15 days per month, referred to as 'chronic migraine'. Botox® (onabotulinumtoxinA) is Health Canada approved for the prophylaxis of headaches in adults with chronic migraine.
Temporomandibular Joint Pain
Temporomandibular disorder (TMD) is a collective term used to describe a group of. conditions involving the temporomandibular joint (TMJ), masticatory muscles, and associated structures. The prevalence of individuals requiring treatment for TMD in the general adult population is estimated at about 16%, with the prevalence among women higher than among men. Botox® can be used for the purpose of muscle relaxation in the treatment of TMD.
Hyperhydrosis
Hyperhidrosis, or excessive sweating disorder, is reported to be approximately 3% of the Canadian population. Botox® is Health Canada approved in the treatment of hyperhidrosis by preventing the stimulation of the sweat glands. Data also supports a 75% reduction in the symptoms of hyperhidrosis as well as an improvement in emotional and physical wellbeing. Patients have also reported a decrease in activity limitations and subsequently an increase in quality of life activities.
Hypertrophic Trapezius Treatment
Hypertrophic trapezius muscle can result in both a therapeutic problem impacting a clients mobility, and quality of life, as well as an aesthetic problem impacting a clients feelings of attractiveness and perception of beauty. The goal of using Botox® treatments to a hypertrophied trapezius muscles is to produce muscle loss that will result in smoothness of muscle, reduces muscle contractility, and overall reduce client symptoms. Improvement of symptoms usually are reported about 6 – 8 weeks after injections.
Hypertrophic Scar Treatment
Scars may not only be visible, but they can also cause pain, itchiness, and other forms of discomfort. Hypertrophic scarring treatment with Botox® has been an emerging procedure in aesthetic medicine to help reduce the visibility and discomfort of scars. For optimal results, scars that are less than 12 months generally have better outcomes.
Facial Flushing
Facial flushing conditions like Rosacea is a chronic, usually recalcitrant and recurrent skin condition with a significant aesthetic aspect. It can affect self-confidence and quality of life. Botox® has emerged as an effective method to treat facial erythema, flushing, and subjective complains associated with Rosacea by decreasing sweat gland activity, sebum production,
and constriction of small blood vessels.